BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32847839)

  • 1. Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study.
    Constantinidou A; Sauve N; Stacchiotti S; Blay JY; Vincenzi B; Grignani G; Rutkowski P; Guida M; Hindi N; Klein A; Thibaud V; Sufliarsky J; Desar I; Steeghs N; Litiere S; Gelderblom H; Jones RL
    ESMO Open; 2020 Aug; 5(4):. PubMed ID: 32847839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study.
    Conforti F; Gronchi A; Penel N; Jones RL; Broto JM; Sala I; Bagnardi V; Napolitano A; Pala L; Pennacchioli E; Catania C; Queirolo P; Grigani G; Merlini A; Stacchiotti S; Comandone A; Vincenzi B; Quagliuolo V; Bertuzzi A; Boglione A; Palassini E; Baldi GG; Blay JY; Ryckewaert T; Toulmonde M; Italiano A; Le Cesne A; Ray-Coquard I; Cruz J; Hernández-León CN; Trufero JM; da Silva Moura D; Muñiz NH; De Pas T
    Eur J Cancer; 2022 Aug; 171():183-192. PubMed ID: 35728378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.
    Schlemmer M; Reichardt P; Verweij J; Hartmann JT; Judson I; Thyss A; Hogendoorn PC; Marreaud S; Van Glabbeke M; Blay JY
    Eur J Cancer; 2008 Nov; 44(16):2433-6. PubMed ID: 18771914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials.
    Young RJ; Natukunda A; Litière S; Woll PJ; Wardelmann E; van der Graaf WT
    Eur J Cancer; 2014 Dec; 50(18):3178-86. PubMed ID: 25459395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
    Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
    J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localised angiosarcomas: the identification of prognostic factors and analysis of treatment impact. A retrospective analysis from the French Sarcoma Group (GSF/GETO).
    Lindet C; Neuville A; Penel N; Lae M; Michels JJ; Trassard M; Terrier P; Birtwisle-Peyrottes I; Valo I; Collin F; Chateau MC; Robin YM; Coindre JM
    Eur J Cancer; 2013 Jan; 49(2):369-76. PubMed ID: 22967726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy for primary cutaneous/soft tissue angiosarcoma: Determining tumor behavior prior to surgical resection.
    Oxenberg J; Khushalani NI; Salerno KE; Attwood K; Kane JM
    J Surg Oncol; 2015 Jun; 111(7):829-33. PubMed ID: 25772798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement.
    DeMartelaere SL; Roberts D; Burgess MA; Morrison WH; Pisters PW; Sturgis EM; Ho V; Esmaeli B
    Head Neck; 2008 May; 30(5):639-46. PubMed ID: 18213722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Prognostic Factors of Primary Splenic Angiosarcoma: A Retrospective Clinical Analysis from China.
    Li R; Li M; Zhang LF; Liu XM; Hu TZ; Xia XJ; Chi JS; Jiang XX; Xu CX
    Cell Physiol Biochem; 2018; 49(5):1959-1969. PubMed ID: 30235449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and outcome of 82 patients with angiosarcoma.
    Abraham JA; Hornicek FJ; Kaufman AM; Harmon DC; Springfield DS; Raskin KA; Mankin HJ; Kirsch DG; Rosenberg AE; Nielsen GP; Desphpande V; Suit HD; DeLaney TF; Yoon SS
    Ann Surg Oncol; 2007 Jun; 14(6):1953-67. PubMed ID: 17356953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiosarcoma of the breast: a difficult surgical challenge.
    Hui A; Henderson M; Speakman D; Skandarajah A
    Breast; 2012 Aug; 21(4):584-9. PubMed ID: 22305554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience of angiosarcoma in the North of England Bone and Soft Tissue Tumour Service.
    Lewis CJ; Gerrand C; Barnes DE; Murray S; Milner RH; Ragbir M
    J Plast Reconstr Aesthet Surg; 2011 Jul; 64(7):884-91. PubMed ID: 21145796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
    Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
    Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (Neo)adjuvant treatment in localised soft tissue sarcoma: The unsolved affair.
    Saponara M; Stacchiotti S; Casali PG; Gronchi A
    Eur J Cancer; 2017 Jan; 70():1-11. PubMed ID: 27866094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.
    Italiano A; Penel N; Robin YM; Bui B; Le Cesne A; Piperno-Neumann S; Tubiana-Hulin M; Bompas E; Chevreau C; Isambert N; Leyvraz S; du Chatelard PP; Thyss A; Coindre JM; Blay JY
    Ann Oncol; 2009 Mar; 20(3):425-30. PubMed ID: 19088169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of Prognostic Features in Primary Cutaneous and Soft Tissue Angiosarcoma After Surgical Resection: A Retrospective Study.
    Lee BL; Chen CF; Chen PC; Lee HC; Liao WC; Perng CK; Ma H; Lin CH
    Ann Plast Surg; 2017 Mar; 78(3 Suppl 2):S41-S46. PubMed ID: 28118230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Complex Management of the Breast Angiosarcoma: A Retrospective Study.
    Cannella L; Perri F; Clemente O; von Arx C; Pizzolorusso A; Di Bonito M; Bracigliano A; Di Marzo M; Della Vittoria Scarpati G; De Chiara A; Tafuto S
    Oncology; 2023; 101(4):234-239. PubMed ID: 36538913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiosarcomas of primary gynecologic origin: a clinicopathologic review and quantitative analysis of survival.
    Kruse AJ; Sep S; Slangen BF; Vandevijver NM; Van Gorp T; Kruitwagen RF; Van de Vijver KK
    Int J Gynecol Cancer; 2014 Jan; 24(1):4-12. PubMed ID: 24257655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma.
    Gortzak E; Azzarelli A; Buesa J; Bramwell VH; van Coevorden F; van Geel AN; Ezzat A; Santoro A; Oosterhuis JW; van Glabbeke M; Kirkpatrick A; Verweij J;
    Eur J Cancer; 2001 Jun; 37(9):1096-103. PubMed ID: 11378339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group.
    Meurer M; Floquet A; Ray-Coquard I; Bertucci F; Auriche M; Cordoba A; Piperno-Neumann S; Salas S; Delannes M; Chevalier T; Italiano A; Blay JY; Mancini J; Pautier P; Duffaud F
    Int J Gynecol Cancer; 2019 May; 29(4):691-698. PubMed ID: 30772825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.